GSK (GSK) news

GSK PLC: Morgan Stanley raises target price to 1900p from 1750p

Morgan Stanley has revised its target price for GSK PLC (LON: GSK), increasing it to 1900p from the previous 1750p, reflecting a positive reassessment of the company’s outlook [1]. The adjustment follows a review of GSK’s strategic direction and operational performance, which the firm views as…

ImportantGSK's Jemperli gets FDA priority review for rectal cancer

Sino Biopharmaceutical - launches new global brand SBP Group

Sino Biopharmaceutical Limited has announced the launch of its new global brand, SBP Group, marking a strategic shift toward international expansion and reinforcing its commitment to innovation in the pharmaceutical sector. The rebranding reflects the company’s evolution from a domestic…

Chugai, GSK sign license agreement for Aid351

Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) has entered into a collaboration agreement with GSK's Global Health Unit (GSK GH) to advance the development of anti-dengue virus antibody drug . The agreement outlines GSK GH's role in evaluating potential funding and initiation of clinical studies .…

Britain's FTSE 100 fell by 0.18%, while Germany's DAX rose by 0.51%.

On August 14, 2026, Britain's FTSE 100 fell by 0.18%, marking a continuation of its five-day losing streak driven by declines in mining and pharmaceutical sectors. Industrial metal price weakness pressured mining stocks, with Antofagasta dropping over 4%, while Glencore, Endeavour, and Fresnillo…